Get the facts about Xarelto® lawsuits from the professionals at Hollis Law Firm.
Xarelto® is a new type of oral anticoagulant, or blood thinner, that was developed by Bayer and Janssen Pharmaceuticals (a New Jersey based unit of Johnson & Johnson). Xarelto was originally approved by the FDA for use as a blood thinner for patients who were at-risk of blood clots after undergoing knee or hip replacement surgery. A fast-track regulatory review by the government made it possible for doctors to prescribe the drug for patients with deep vein thrombosis and pulmonary embolism.
Blood clots can obstruct the flow of blood to important organs such as the brain and lungs. Blood thinners, such as Warfarin, were developed in the 1950s to help prevent these blood clots in at-risk individuals. Like other anticoagulants, Xarelto is designed to prevent clotting. However, the older anti-coagulation drugs are prescribed in several doses over a period of time, and Xarelto is prescribed to be taken in one dose.
Xarelto has been found to cause more internal abdominal bleeding than Warfarin. Unlike Warfarin, there is no antidote for Xarelto, so if bleeding occurs, it will continue uncontrollably, until the drug is no longer in the system. The drug cannot be flushed out of the system using dialysis and in some cases, the uncontrollable bleeding can be fatal.
The irreversible bleeding caused by Xarelto can lead to expensive medical bills, dangerous injuries, and even death. Some individuals and/or their families have filed lawsuits for the physical, emotional, and financial sufferings caused by this drug.
If you would like to learn more about medical lawsuits relating to drugs such as Xarelto, the Hollis Law Firm is available to answer any questions you may have. Our team of attorneys will review your case and if it is advisable to file a Xarelto lawsuit, will help you understand the legal process. Complete the contact form on this page or call us toll-free at (800) 701-3672 to get started.